ATE67211T1 - C17-20-lyase-inhibitoren. - Google Patents

C17-20-lyase-inhibitoren.

Info

Publication number
ATE67211T1
ATE67211T1 AT88106397T AT88106397T ATE67211T1 AT E67211 T1 ATE67211 T1 AT E67211T1 AT 88106397 T AT88106397 T AT 88106397T AT 88106397 T AT88106397 T AT 88106397T AT E67211 T1 ATE67211 T1 AT E67211T1
Authority
AT
Austria
Prior art keywords
compounds
lyase inhibitors
beta
androst
cyclopropylamino
Prior art date
Application number
AT88106397T
Other languages
English (en)
Inventor
Michael R Angelastro
Thomas R Blohm
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE67211T1 publication Critical patent/ATE67211T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
AT88106397T 1987-04-22 1988-04-21 C17-20-lyase-inhibitoren. ATE67211T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4117287A 1987-04-22 1987-04-22
EP88106397A EP0288053B1 (de) 1987-04-22 1988-04-21 C17-20-Lyase-Inhibitoren

Publications (1)

Publication Number Publication Date
ATE67211T1 true ATE67211T1 (de) 1991-09-15

Family

ID=21915133

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88106397T ATE67211T1 (de) 1987-04-22 1988-04-21 C17-20-lyase-inhibitoren.

Country Status (19)

Country Link
EP (1) EP0288053B1 (de)
JP (1) JP2711672B2 (de)
KR (1) KR960015037B1 (de)
CN (1) CN88102176A (de)
AT (1) ATE67211T1 (de)
AU (1) AU606677B2 (de)
CA (1) CA1326234C (de)
DE (1) DE3864725D1 (de)
DK (1) DK217588A (de)
ES (1) ES2038712T3 (de)
FI (1) FI88397C (de)
GR (1) GR3002713T3 (de)
HU (1) HU198511B (de)
IL (1) IL86139A (de)
NO (1) NO169346C (de)
NZ (1) NZ224288A (de)
PH (1) PH24090A (de)
PT (1) PT87294B (de)
ZA (1) ZA882717B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US4954488A (en) * 1989-06-14 1990-09-04 Merrell Dow Pharmaceuticals Inc. Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
US4966898A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5252319A (en) * 1990-06-12 1993-10-12 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5256408A (en) * 1990-06-12 1993-10-26 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
CA2132449C (en) * 1992-03-31 2002-09-10 Susan E. Barrie 17 - substituted steroids useful in cancer treatment
US5604213A (en) * 1992-03-31 1997-02-18 British Technology Group Limited 17-substituted steroids useful in cancer treatment
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
CN1329394C (zh) 2000-11-17 2007-08-01 武田药品工业株式会社 新咪唑衍生物、其制备方法及其用途
ATE502030T1 (de) 2000-11-20 2011-04-15 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
EP1348706B1 (de) 2000-12-08 2009-08-19 Takeda Pharmaceutical Company Limited Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung
ES2475945T3 (es) 2009-06-26 2014-07-11 Novartis Ag Derivados imidazolidin-2 -ona 1,3-disustituida como inhibidores de CYP 17
KR101926320B1 (ko) 2010-08-04 2018-12-06 펠피큐어 파마슈티걸즈 아이엔씨 전립선 암종의 치료를 위한 병용 요법
WO2012035078A1 (en) 2010-09-16 2012-03-22 Novartis Ag 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
CA2834224A1 (en) 2011-04-28 2012-11-01 Novartis Ag 17.alpha.-hydroxylase/c17,20-lyase inhibitors
AU2014241816B9 (en) 2013-03-14 2019-02-14 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
US10093620B2 (en) 2014-09-12 2018-10-09 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
WO2018080933A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL302932A (de) * 1962-12-31
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
CN88102176A (zh) 1988-11-23
NO169346B (no) 1992-03-02
AU1471988A (en) 1988-10-27
DK217588D0 (da) 1988-04-21
ZA882717B (en) 1988-10-17
HU198511B (en) 1989-10-30
JP2711672B2 (ja) 1998-02-10
KR960015037B1 (ko) 1996-10-24
FI88397C (fi) 1993-05-10
EP0288053A1 (de) 1988-10-26
IL86139A0 (en) 1988-11-15
HUT47307A (en) 1989-02-28
NO881746L (no) 1988-10-24
NO881746D0 (no) 1988-04-21
JPS63284195A (ja) 1988-11-21
PT87294B (pt) 1992-08-31
GR3002713T3 (en) 1993-01-25
CA1326234C (en) 1994-01-18
PT87294A (pt) 1988-05-01
NO169346C (no) 1992-06-10
FI881877A (fi) 1988-10-23
FI881877A0 (fi) 1988-04-21
KR880012633A (ko) 1988-11-28
DK217588A (da) 1988-10-23
AU606677B2 (en) 1991-02-14
NZ224288A (en) 1989-12-21
EP0288053B1 (de) 1991-09-11
IL86139A (en) 1993-02-21
PH24090A (en) 1990-03-05
DE3864725D1 (de) 1991-10-17
ES2038712T3 (es) 1993-08-01
FI88397B (fi) 1993-01-29

Similar Documents

Publication Publication Date Title
DE3864725D1 (de) C17-20-lyase-inhibitoren.
EP0413270A3 (en) 4-substituted 17beta-(cyclopropylamino)androst-5-en-3beta-ol and related compounds useful as c17-20 lyase inhibitors
GB9514451D0 (en) Sustained-release formulation
NZ217773A (en) Method of treatment for allergy using an n-substituted arylalkyl-heterocyclic amine
GR3020797T3 (en) 4-substituted 17-beta-(cyclopropyloxy)androst-5-EN-3-beta-OL and related compounds useful as C17-20 lyase inhibitors
DE68902137D1 (de) Verfahren zur qualitaetsverbesserung von wachshaltigen destillaten oder raffinaten durch wasserstoffbehandlung und hydroisomerisation.
ZA882715B (en) 17beta-(cyclopropyloxy)-androst-5-en-3beta-ol and related compounds useful as c17-20 lyase inhibitors
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
DE69432626D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
ZA912236B (en) Hydroxymethyl-indolizidines and quinolizidines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee